Science Exchange Closes $77.5M to Streamline Life Sciences R&D

Science Exchange has raised $77,500,000 in investment capital from investors. The company operates as the first purchasing and supplier orchestration platform specifically designed for life sciences organizations. Its core mission involves modernizing and streamlining how R&D teams and their suppliers collaborate within the scientific research ecosystem. The Science Exchange platform integrates purchasing, supplier management, and payment processing into a single digital marketplace. It provides access to a network of 3,800 pre-contracted suppliers and allows for the integration of existing supplier relationships. The system simplifies the intake process for scientists to procure necessary services and products, while guiding them through required approvals and compliance procedures. Key features include the secure transfer of large files, integration of supplier data into Electronic Lab Notebooks (ELNs), and an automated payment system that validates invoices and facilitates prompt supplier payments. Leading life sciences companies such as BMS, AbbVie, Gilead, and Astellas utilize Science Exchange to accelerate research, automate manual tasks, and advance their programs. This significant funding round underscores investor confidence in Science Exchange's platform and its potential to transform R&D procurement. The company plans to use the newly secured capital to accelerate its platform's development, expand its market presence, and invest in strategic growth initiatives aimed at further enhancing its offerings. Looking ahead, Science Exchange aims to continue its trajectory of growth, focusing on expanding its capabilities and network. The company is poised to further solidify its role in enabling life sciences organizations to enhance efficiency, accelerate scientific discovery, and bring innovative treatments to market faster.